期刊文献+

金黄色葡萄球菌耐药性调查 被引量:1

下载PDF
导出
摘要 目的:了解我院金黄色葡萄球菌的耐药情况。方法:对1998-01/04分离的58株金黄色葡萄球菌药敏结果进行分析。结果:分离出5l株耐苯唑西林的金黄色葡萄球菌(MRSA),占87.9%,且都为多重耐药株。14种抗生素中万古霉素活性最好,耐药率为0%;其次为利福平、氯霉素、丁胺卡那霉素、头孢哌酮、头孢唑啉,耐药率分别为23.5%、35_3%、43.1%、60.8%、64.7%;对青霉素、SMZ CO、庆大霉素、氧氟沙星、环丙沙星、头孢他啶、头孢呋新耐药率高,均在70%以上。结果:我院金黄色葡萄球菌感染中MRSA所占比例极高,首选用药为万古霉素,可联合使用利福平、丁胺卡那或氯霉素。注意合理使用抗生素,减少耐药菌的产生。
作者 严晓敏 唐勤
出处 《世界感染杂志》 2001年第5期420-422,共3页 World Journal of Infection
  • 相关文献

参考文献6

二级参考文献7

共引文献146

同被引文献33

  • 1Tenover FC, Mohanned MJ, Gorton TS, et al. Detection and reporting of organisms producing extended spectrum betalactamases: survey of laboratories in Connecticut. J Clin Microbiol, 1999,37 (12) : 4065-4070.
  • 2Wiener J, Quinn JP, Bradford PA, et al. Multiple antibiotics-resistant Klebsiella and Escherichia coli in nursing homes.JAMA, 1999,281(6) : 517-523.
  • 3Wong-Beringer A, Hinder J, Loeloff M, et al. Moleculer correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime. Ciln Infect Dis, 2002,34 (2) : 135-146.
  • 4Lee SH, Jeong SH. Antibiotics susceptibility of bacterial strains isolate from patients with various infections. Lett Appl Microbiol,2002,34(3) :215-212.
  • 5Vahaboglu H, Dodanli S, Eroglu C, et al. Characterization of multiple-antibiotic-resistant Salmonella typhimurium strains:molecular epidemiology PER-1 producing isolates and evidence fornosocomial plasmid exchange by a clone. J Clin Microbiol, 1996 ,34(12) :2942-2946.
  • 6Pfaller MA, Jones RN. Antimicrobial susceptibility of inducible AmpC beta-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection(MYSTIC) Programme, Europe 1997-2000. Int J Antimicrob Agents ,2002,19(3) :383-388.
  • 7Gal Z, Szabo D, Kovacs P, et al. Beta-lactam susceptibility patterns and investigation of cephalosporing beta-lactamases of Gram-negative extraintestinal clinical isolates. Int J Antimicrob Agents, 2000,16(4) :395-400.
  • 8Eltahawy AT. Febrile neutropenia. Etiology of infection,empirical treatment and prophylaxis. Saudi Med J, 2003, 24 (4):331-336.
  • 9Dale DC. Colony-stimulating factors {or the management of neutropenia in cancer patients. Drugs, 2002,1 : 1-15.
  • 10Wiedermann FJ, Mittermayr M, Hoffmann G, et al. Recobinant glanulocyte colony-stimulating factor (G-CSF) in infectious dieases: still a debate. Wien Kiln Wochenschr, 2001, 113(3-4):90-96.

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部